Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States

Limited data exists regarding the safety of the COVID-19 2023–2024 vaccine formulations and whether the safety profiles differ from the original formulations. We evaluated the association between the BNT162b2 XBB COVID-19 vaccine and the risk of 20 pre-specified adverse events of special interest (A...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vaccine 2024-12, Vol.45, p.126629, Article 126629
Hauptverfasser:	Sun, Jenny W., Dodge, Laura E., Kim, Eric J., Zhou, Li, Mather, Susan, Goebe, Henry, Charpentier, Nicola, Nespithal, Kirsten, Asomaning, Kofi, Wang, Florence T.
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 vaccine Epidemiology Vaccine safety
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!